documents: FDA-2026-N-2590-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-2590-0001 | FDA | FDA-2026-N-2590 | Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests | Proposed Rule | Request for Comment | 2026-03-30 | 2026 | 3 | 2026-03-30 | 2026-05-30 | 2026-04-13 09:00:30 | 2026-06064 | 1 | 0 | 09000064b92437b6 |